How MBM drives smarter pharmacy cost, compliance, and utilization management

Key takeaways

• Aligns clinical expertise, regulatory compliance, and utilization management within a coordinated framework
• Improves visibility into pharmacy cost drivers and utilization trends
• Supports clinically appropriate medication use through structured, evidence-based review processes
• Strengthens financial oversight while advancing member health outcomes

Medical Benefits Management (MBM) is a clinically governed framework that manages medications covered under the medical benefit through utilization review, regulatory oversight, and integrated cost management—supporting a more connected care experience.

U.S. prescription drug spending grew faster  than overall healthcare spending in the most recent reporting year, according to Centers for Medicare & Medicaid Services (CMS) National Health Expenditure data, underscoring the accelerating financial pressure on health plans. Medication Benefits Management (MBM) helps health plans address this complexity through a clinically governed, data-driven framework that aligns clinical expertise, regulatory compliance, and utilization management across medical and pharmacy benefits. By connecting pharmacy insights with broader health strategies, MBM provides clearer visibility into cost drivers, supports appropriate medication use, and supports oversight across benefit programs. Improved visibility into utilization trends and specialty spend drivers supports more informed forecasting and greater cost predictability, while reinforcing evidence-based decisions that support better member outcomes.

MBM operates as a health plan–aligned solution that can be white-labeled, enabling plans to advance their own medical and pharmacy benefit offerings across commercial, government, and individual lines of business.

Health Plan Challenges in Integrated Health Management

Cost containment is becoming increasingly complex as health plans navigate fragmented care delivery, rising pharmacy spend, and growing reliance on high-cost specialty therapies. Specialty medications account for more than half of total  drug spending despite representing a small share of prescriptions, according to IQVIA analyses of U.S. medicine spending trends, underscoring their outsized financial impact. Sustainable financial management requires a coordinated, data-informed approach to managing risk across the full spectrum of care. While high-cost specialty therapies can deliver meaningful clinical value, they also introduce significant financial volatility when not managed within an integrated framework. Without alignment across pharmacy, medical, and care management functions, health plans face greater difficulty managing cost and utilization, maintaining regulatory compliance, and ensuring appropriate utilization.
 

Role of MBM in Integrated Health Management

MBM plays a central role in advancing integrated health management by aligning clinical oversight, data insights, and care coordination across the continuum. Within a model grounded in collaborative health care, physicians, pharmacists, care managers, and plan leaders share evidence and align on common goals to ensure care decisions are clinically appropriate, cost-effective, and consistent. This coordinated approach improves visibility into utilization patterns, reduces unnecessary variation, and supports earlier, more informed interventions. By connecting medical benefit strategy to broader population health objectives, health plans can improve financial stewardship while delivering more seamless, whole-person care.
 

Managing Regulatory Complexity with Confidence

Evolving requirements and oversight have made health care compliance a growing priority for health plans seeking greater accountability across their benefit programs. Effective risk management in healthcare requires more than monitoring policy updates; it demands structured processes, clinical governance, and real-time visibility into utilization patterns. Tools such as prior authorizations help ensure treatments meet evidence-based guidelines, support appropriate care, and reduce unnecessary variation. As one Carelon physician leader explains:

“As a physician, I know how vital it is for prior authorization determinations to be made quickly.” 

Federal oversight guidance, including compliance program recommendations from the U.S. Department of Health and Human Services Office of Inspector General (OIG), commonly emphasizes structured compliance programs and utilization review  as essential safeguards against inappropriate spending and regulatory risk. When regulatory safeguards are integrated into broader medical and pharmacy benefit strategies, health plans can navigate complexity with greater confidence, strengthen oversight, and reduce exposure to financial and compliance risk.

Expertise and Evidence in Clinical Care Coordination

Effective clinical care coordination depends on aligning expertise and evidence across disciplines to guide informed, consistent decision-making. When physicians, pharmacists, nurses, and care managers operate from shared clinical standards and data insights, treatment plans are more likely to reflect best practices and whole health needs. This clinically aligned model reduces unnecessary variation, supports appropriate utilization, and improves continuity across care settings. Structured care coordination is linked to improved quality outcomes  and more efficient resource use across complex patient populations, according to research summarized by the Agency for Healthcare Research and Quality (AHRQ).. By embedding evidence-based protocols into care workflows, health plans can reinforce quality oversight while promoting more seamless experiences and measurable impact in population health outcomes.
 

Enhancing Health Plan Value through Medical Benefits Management

MBM enhances health plan value by bringing greater transparency, clinical discipline, and alignment to health care spending. By integrating clinical oversight with data analytics and care coordination, health plans gain clearer insight into cost drivers, utilization trends, and opportunities for improvement. Prescription drug spending continues to represent a growing share of national health expenditures, , according to CMS National Health Expenditure data, reinforcing the importance of disciplined cost oversight and utilization management  within health plan benefit programs.

This structured approach supports appropriate care decisions, reduces avoidable variation, and improves financial stewardship across medical and pharmacy benefits. When MBM is embedded within a broader integrated health strategy, health plans are better positioned to manage complexity, demonstrate measurable improvements, support return on investment, and advance their long-term competitive position.
 

Considerations When Adopting an MBM Model

When evaluating the adoption of an MBM model, health plans should carefully assess their goals, data readiness, and partner capabilities to ensure a strong fit with broader benefit strategies. Key considerations include the depth of clinical expertise, the ability to integrate analytics across medical and pharmacy spend, and a partner’s track record in demonstrating measurable impact. Identifying a partner with the right balance of clinical rigor, operational discipline, and collaborative approach can make a significant difference in long-term success. Additionally, health plans should consider how technology, governance structures, and communication protocols will support sustainability and adaptability as healthcare needs evolve.